Streetbeat News

Revenues

IMAB

I-Mab reported a significant improvement in its financial performance for FY23, with EPS improving to $(0.76) from $(1.63) YoY and revenue increasing to $3.9M from $(32.1M) YoY. The non-GAAP adjusted net loss decreased to $155.7 million from $309.7 million YoY, with per share and per ADS losses also reducing significantly.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 9:03 pm

EVOK

Evoke Pharma forecasts its FY24 net revenue to be approximately $14M, closely aligning with the estimated $14.017M by analysts.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 8:50 pm

PHR

Phreesia has reaffirmed its 2025 revenue forecast to be in the range of $424M-$434M, aligning with the estimated $428.12M. Additionally, the company has updated its adjusted EBITDA outlook, improving it from $10M-$20M to $12M-$20M.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 8:48 pm

KRT

Karat Packaging anticipates its net sales for the first quarter of 2024 to rise by a low to mid-single digit percentage compared to the same quarter of the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 8:46 pm

CDLX

Cardlytics forecasts Q1 revenue to be between $70M-$73M, surpassing the estimated $66.46M.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 8:45 pm

AMPS

Altus Power projects its FY24 revenue to be in the range of $200M-$222M, which is below the estimated $224.877M.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 8:44 pm

KODK

Eastman Kodak reported a 9.84% decrease in Q4 sales, totaling $275.00 million compared to $305.00 million in the same period last year.

Portfolio Pulse from Happy Mohamed

March 14, 2024 | 8:43 pm

AKBA

Akebia Therapeutics reported Q4 sales of $56.200 million, surpassing the analyst consensus estimate of $55.393 million by 1.46% and marking a 1.85% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 8:36 pm

BLNK

Blink Charging projects FY24 revenue to be between $165M-$175M, aligning with the $171.2M estimate. The company aims for a positive adjusted EBITDA by December 2024 and targets a gross margin of approximately 33% for the full year.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 8:35 pm